All News

A big thank you to you, our readers, for lending your voice to Pharm Exec's editorial mission-giving you the information you need and want. Click ahead for a look at some of the future topics we'll be tackling.

Is report worth a look as potential springboard to addressing future EU ties in healthcare-or just more bluster?

How STEM helps women advance from lab bench to boardroom.

Amid political and economic turmoil in recent years, and resulting shortcomings in healthcare budget, medical infrastructure, and drug access, the Ukraine government is championing the introduction of an unprecedented set of reforms, prompting a significant evolution in the country's healthcare system.

Click the title above to open the Pharmaceutical Executive September 2017 issue in an interactive PDF format.

Click the title above to open the Pharmaceutical Executive August 2017 issue in an interactive PDF format.

Branded generics in select emerging markets can offer above-market returns, writes Renaud Savary.

Just as internal company compliance regulation needs to change, so too does compliance education: We need the good people in pharma to think and we must empower them to do so, writes Dr. Nick Broughton.

If it feels like the media’s scrutiny of pharma has intensified recently, there's a reason-it has, as the results of our 13th Annual Press Audit indicate.

As digital technologies transform drug development and marketing, a retooled medical affairs function can be a competitive differentiator.

Highlighting a sampling of new digital health devices that span the wide focus terrain in health technology.